These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4562750)

  • 1. Reducing the number of inferior treatments in clinical trials.
    Flehinger BJ; Louis TA; Robbins H; Singer BH
    Proc Natl Acad Sci U S A; 1972 Oct; 69(10):2993-4. PubMed ID: 4562750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exact group-sequential designs for clinical trials with randomized play-the-winner allocation.
    Stallard N; Rosenberger WF
    Stat Med; 2002 Feb; 21(4):467-80. PubMed ID: 11836730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential or fixed sample trial design? A case study by stochastic simulation.
    Skovlund E; Walløe L
    J Clin Epidemiol; 1991; 44(3):265-72. PubMed ID: 1999686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials designed to evaluate therapeutic preferences.
    Baskerville JC; Toogood JH; Mazza J; Jennings B
    Stat Med; 1984; 3(1):45-55. PubMed ID: 6729288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential allocation in clinical trials comparing two exponential survival curves.
    Louis TA
    Biometrics; 1977 Dec; 33(4):627-34. PubMed ID: 338043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated confidence intervals for group sequential clinical trials.
    Jennison C; Turnbull BW
    Control Clin Trials; 1984 Mar; 5(1):33-45. PubMed ID: 6713906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flexible multi-stage design for phase II oncology trials.
    Tan MT; Xiong X
    Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian analysis of the two-period crossover design for clinical trials.
    Grieve AP
    Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a misspecification of response rates on type I and type II errors, in a phase II Simon design.
    Baey C; Le Deley MC
    Eur J Cancer; 2011 Jul; 47(11):1647-52. PubMed ID: 21493059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical inference and the design of clinical trials.
    Berry DA
    Biomedicine; 1980 Feb; 32(1):4-7. PubMed ID: 7370380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-stage trial design for testing treatment, self-selection and treatment preference effects.
    Rücker G
    Stat Med; 1989 Apr; 8(4):477-85. PubMed ID: 2727471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential clinical trials for normal variates using interval composite hypotheses.
    Lachin JM
    Biometrics; 1981 Mar; 37(1):87-101. PubMed ID: 7248445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of randomized and historical controls in clinical trials.
    Pocock SJ
    J Chronic Dis; 1976 Mar; 29(3):175-88. PubMed ID: 770493
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions.
    Woods SW; Sholomskas DE; Shear MK; Gorman JM; Barlow DH; Goddard AW; Cohen J
    Am J Psychiatry; 1998 Oct; 155(10):1446-8. PubMed ID: 9766781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size determination in clinical trials with an emphasis on exponentially distributed responses.
    Gross AJ; Hunt HH; Cantor AB; Clark BC
    Biometrics; 1987 Dec; 43(4):875-83. PubMed ID: 3427172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing power and minimizing treatment failures in clinical trials.
    Rosenberger WF; Huc F
    Clin Trials; 2004; 1(2):141-7. PubMed ID: 16281886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The most frequently asked question to a statistician: The sample size.
    Sormani MP
    Mult Scler; 2017 Apr; 23(5):644-646. PubMed ID: 28273773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of unequal allocation in survival trials.
    Sposto R; Krailo MD
    Stat Med; 1987 Mar; 6(2):119-25. PubMed ID: 3589241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.